BSE filing, NSE: ADVANIHOTR. Summary written from the filing by ALFA Finder's alert engine.
Advani Hotels & Resorts (India) Ltd: key numbers
- Share price
- ₹44.91
- Market cap
- ₹415.1 Cr
- Revenue (annual)
- ₹106.7 Cr
- Net profit (annual)
- ₹23.86 Cr
- P/E (TTM)
- 18.1×Sector 44.5×
- Promoter holding
- 50.25%+0.00% QoQ
- FII holding
- 0.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Advani Hotels & Resorts (India) Ltd
All →Advani Hotels & Resorts (India) Other Announcement
The company submitted its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI Regulation 31.
Advani Hotels & Resorts (India) Annual General Meeting
Advani Hotels & Resorts (India) Limited announced voting results for its 39th Annual General Meeting. All resolutions, including adoption of financial statements, were passed with majority.
Advani Hotels & Resorts (India) Annual General Meeting
Advani Hotels held its 39th AGM on September 22, 2026. Routine items including financial statements adoption and director reappointments were approved.
Advani Hotels & Resorts (India) Annual Report
Advani Hotels & Resorts (India) Limited has submitted its Annual Report for the financial year 2025-2026. This filing complies with Regulation 34 of SEBI LODR.
Advani Hotels & Resorts (India) Annual General Meeting
Advani Hotels & Resorts has submitted its 39th Annual Report and notice for the AGM scheduled on September 22, 2026.
Advani Hotels & Resorts (India) Results Update
Advani Hotels & Resorts (India) Ltd. reported Q1 FY27 total income of ₹22.05 Crore. The Board also approved an expansion of 28 to 56 additional rooms.
- Value
- ₹22.05 Cr
Other other announcement announcements
All →Sundrop Brands Other Announcement
Sundrop Brands Limited announced that its Registrar and Share Transfer Agent, KFin Technologies Limited, is shifting its corporate office. The change takes effect on December 01, 2026.
Akums Drugs & Pharmaceuticals Other Announcement
Akums Drugs and Pharmaceuticals Limited has fully utilized its IPO proceeds totaling Rs. 680 Crore as of September 30, 2026. Consequently, further monitoring agency reports are no longer required.
- Value
- ₹680.0 Cr
DSJ Keep Learning Other Announcement
DSJ Keep Learning Ltd filed its quarterly shareholding pattern for the quarter ended 30 September 2026. The filing reports promoter and public holdings with no transaction or monetary amount involved.
RBZ Jewellers Other Announcement
RBZ Jewellers Limited has reconstituted its Audit, Nomination and Remuneration, and Stakeholder Relationship Committees. Mr. Rajiv Mehta, an Independent Director, was appointed as a member of these committees.
Vidya Wires Other Announcement
Vidya Wires intimated a scheduled TV interview with Zee Business on 5 Nov 2026. No UPSI is expected to be disclosed.
Asarfi Hospital Other Announcement
Asarfi Hospital Limited filed its half-yearly shareholding pattern under Regulation 31(1)(b) for the period ended 30 September 2026. The filing shows promoter and public holdings, with no transaction or corporate event.